Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50–64 years of age

✍ Scribed by R. Baxter; P.A. Patriarca; K. Ensor; R. Izikson; K.L. Goldenthal; M.M. Cox

• Book ID: 116963463
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 288 KB
• Volume: 29
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2011.01.039